Innate tumor immune surveillance.
Smyth
Mark J
MJ
Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, 3002, Victoria, Australia.
Swann
Jeremy
J
Hayakawa
Yoshihiro
Y
D000818:Animals; D016026:Bone Marrow Transplantation; D016207:Cytokines / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D007157:Immunologic Surveillance; D007370:Interferon Type I / Q000502:physiology; D007378:Interleukins / Q000502:physiology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology* / Q000473:pathology; D011971:Receptors, Immunologic / Q000276:immunology; D055607:Receptors, Natural Killer Cell; D012513:Sarcoma, Experimental / Q000276:immunology / Q000556:secondary
D016207:Cytokines; D007370:Interferon Type I; D007378:Interleukins; D011971:Receptors, Immunologic; D055607:Receptors, Natural Killer Cell